Skip to main content
. 2021 Apr 19;320(6):F1133–F1151. doi: 10.1152/ajprenal.00614.2020

Figure 2.

Figure 2.

Figure 2.

Sacubitril/valsartan (Sac/Val) treatment improved glomerulosclerosis in db/db mice. A: representative images of periodic acid-Schiff staining of kidney sections. The mesangial expansion score was defined by the percentage of the mesangial area in the glomerular tuft area. The mesangial area was determined by assessment of periodic acid-Schiff-positive and nucleus-free areas in the mesangium; n = 4 per group. Scale bar = 100 µm. B and C: immunofluorescence staining of kidney sections for fibronectin (B) and collagen type IV (C). Data were quantified using the ratio of total pixel intensity vs. glomerular area; n = 6 per group. D: quantitative PCR analysis of mRNA levels of fibronectin and collagen type IV in the kidneys from each group; n = 6−9 per group. E: quantitative PCR analysis of mRNA levels of genes involved in profibrotic factors and signaling pathways, transforming growth factor-β (TGF-β), connective tissue growth factor (CTGF), plasminogen activator inhibitor-1 (PAI1), and α-smooth muscle actin (α-SMA); n = 6−9 per group. Data are presented as means ± SE. Veh, vehicle.